| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 03/14/2002 | WO2002020060A1 Vp22 protein/nucleic acid aggregates, uses thereof |
| 03/14/2002 | WO2002020038A2 Method for down-regulating ige |
| 03/14/2002 | WO2002020034A1 'pseudo'-native chemical ligation |
| 03/14/2002 | WO2002020033A1 Polymer-modified synthetic proteins |
| 03/14/2002 | WO2002019963A2 Synthetic erythropoiesis stimulating proteins |
| 03/14/2002 | WO2001081581A3 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 03/14/2002 | WO2001078655A3 Methods and compositions for heat shock protein mediated immunotherapy of melanoma |
| 03/14/2002 | WO2001077147A3 New bromodomain protein |
| 03/14/2002 | WO2001064920A3 Hybrid expression of neisserial proteins |
| 03/14/2002 | WO2001061007A3 Fibroblast growth factor-23 molecules and uses thereof |
| 03/14/2002 | WO2001044497A3 Protein kinase regulation |
| 03/14/2002 | US20020032312 Recombinant multispecific molecule comprising an anti-Fc receptor portion and an anti-target portion. |
| 03/14/2002 | US20020031806 Purified human erythropoietin receptor protein fragment and antibodies derived therefrom |
| 03/14/2002 | DE10043227A1 Neuartiges entwicklungsbiologisches Gen Novel biological developmental gene |
| 03/14/2002 | CA2730627A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2422204A1 Human antibodies against pseudomonas aeruginosa lps derived from transgenic mice |
| 03/14/2002 | CA2422114A1 Novel human cancer/testis antigen and gene thereof |
| 03/14/2002 | CA2421922A1 Proteases |
| 03/14/2002 | CA2421842A1 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 03/14/2002 | CA2421380A1 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | CA2421274A1 Method for down-regulating ige |
| 03/14/2002 | CA2421271A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2421200A1 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | CA2421195A1 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | CA2421191A1 Methods and compositions for in vitro targeting |
| 03/14/2002 | CA2421187A1 Family member of inhibitor of apoptosis proteins |
| 03/14/2002 | CA2421070A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 03/14/2002 | CA2421041A1 Caveolin peptides and their use as therapeutics |
| 03/14/2002 | CA2417660A1 Vp22 protein/nucleic acid aggregates, uses thereof |
| 03/14/2002 | CA2412279A1 "pseudo"-native chemical ligation |
| 03/14/2002 | CA2412278A1 Polymer-modified synthetic proteins |
| 03/14/2002 | CA2412277A1 Synthetic erythropoiesis stimulating proteins |
| 03/13/2002 | EP1186614A2 Crystal structure of the 30S ribosome bound to antibiotics |
| 03/13/2002 | EP1185655A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf) |
| 03/13/2002 | EP1185652A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 03/13/2002 | EP1185650A1 Head trauma induced cytoplasmatic calcium binding protein |
| 03/13/2002 | EP1185648A2 Methods and compositions for inhibiting neoplastic cell growth |
| 03/13/2002 | EP1185645A1 Adipocyte complement related protein homolog zacrp7 |
| 03/13/2002 | EP1185644A1 Assays for caspase activity using green fluorescent proteins |
| 03/13/2002 | EP1185643A1 Adipocyte complement related protein homolog zacrp5 |
| 03/13/2002 | EP1185642A2 Compositions and methods for the treatment of tumor |
| 03/13/2002 | EP1185641A1 Cytokine receptor mouse zcytor10 |
| 03/13/2002 | EP1185554A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof |
| 03/13/2002 | EP0826058B1 Chimeric mcp and daf proteins with cell surface localizing domain |
| 03/13/2002 | CN1340104A Glucose dehydrogenase fusion proteins and their utilization in expression systems |
| 03/13/2002 | CN1340103A Complex-forming proteins |
| 03/13/2002 | CN1340059A Peptides |
| 03/12/2002 | US6355444 Detecting cancer marker in sample; obtain hybridoma sample, incubate with antibody, detect bound antibody |
| 03/12/2002 | US6355254 Pathogenic Escherichia coli associated protein EspA |
| 03/12/2002 | US6355228 Oral care product comprising a mutan binding domain |
| 03/12/2002 | CA2189657C Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 03/12/2002 | CA2034741C Therapeutic antibody based fusion proteins |
| 03/07/2002 | WO2002018637A2 Diagnosis and treatment of prostate cancer |
| 03/07/2002 | WO2002018572A2 Membrane penetrating peptides and uses thereof |
| 03/07/2002 | WO2002018447A1 Fusion protein containing additional cationic amino acids and improvement of bio-operation by using same |
| 03/07/2002 | WO2002018432A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 03/07/2002 | WO2002017949A2 Novel functions for dp214 |
| 03/07/2002 | WO2001079269A3 Lipid binding protein 4 |
| 03/07/2002 | WO2001074855A3 Compositions and methods for dendritic cell-based immunotherapy |
| 03/07/2002 | WO2001058949A3 Heterologous polypeptide of the tnf family |
| 03/07/2002 | WO2001055178A3 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 03/07/2002 | WO2001053325A3 Method of affinity purifying proteins using modified bis-arsenical fluorescein |
| 03/07/2002 | WO2001046231A3 Polynucleotides and polypeptides encoded thereby |
| 03/07/2002 | WO2001040474A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/07/2002 | US20020028914 Chimeric toxins for targeted therapy |
| 03/07/2002 | US20020028205 May be comprised of a heavily glycosylated mucin part, which mediates binding to selectins, such as PSGL-1; absorber to prevent a hyperacute rejection of a xenotransplant |
| 03/07/2002 | US20020028203 T cell inhibitory receptor compositions and uses thereof |
| 03/07/2002 | CA2420652A1 Vertebrate intestinal protein which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 03/06/2002 | EP1184454A2 Nav2 channel gene-deficient non-human animals |
| 03/06/2002 | EP1183358A1 Targeted angiogenesis |
| 03/06/2002 | EP1183355A1 T-bet compositions and methods of use thereof |
| 03/06/2002 | EP1183353A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 03/06/2002 | EP1183348A2 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 03/06/2002 | EP1183346A1 Method for generating split, non-transferable genes that are able to express an active protein product |
| 03/06/2002 | EP1183271A1 Polymer conjugates of hedgehog proteins and uses |
| 03/06/2002 | CN1339066A Alzheimer's disease secretase |
| 03/06/2002 | CN1338473A Fusion protein with angiogenesis suppression action |
| 03/06/2002 | CN1338463A Method for improving stability of polypeptide in body and its application |
| 03/05/2002 | US6352971 Polypeptides with amino acid sequences |
| 02/28/2002 | WO2002016611A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 02/28/2002 | WO2002016561A2 Mfq-111, a novel human gtpase like protein |
| 02/28/2002 | WO2002016436A2 ANTIBODIES TO HUMAN IL-1$g(b) |
| 02/28/2002 | WO2002016415A2 Identification of a cam-kinase ii inhibitor |
| 02/28/2002 | WO2002016414A2 Composition for the elimination of autoreactive b-cells |
| 02/28/2002 | WO2002016413A2 Cripto tumour polypeptide |
| 02/28/2002 | WO2002015701A2 Bacillus thuringiensis crystal protein hybrids |
| 02/28/2002 | WO2001085779A3 Protein complexes and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085762A3 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001079271A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079258A9 Albumin fusion proteins |
| 02/28/2002 | WO2001070984A3 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 02/28/2002 | WO2001068852A3 Apolipoprotein-a-i regulation of t-cell signalling |
| 02/28/2002 | WO2001042474A3 Interferon-like molecules and uses thereof |
| 02/28/2002 | WO2001038547A3 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 02/28/2002 | WO2001030812A3 Activation of hcv-specific t cells |
| 02/28/2002 | WO2000077037A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/28/2002 | US20020026036 Constructing cassette vector by inserting cDNA coding for heavy chain constant region of human antibody into expression vector for animal cell use, establishing cloning site, digesting cdna coding for heavy chain, inserting into vector |
| 02/28/2002 | US20020025513 Antigen/antibody specificity exchanger |
| 02/28/2002 | CA2674888A1 Anti-ige vaccines |
| 02/28/2002 | CA2674838A1 Anti-ige vaccines |